Indication | Allopathic |
---|---|
Manufacturer | Cipla Ltd. |
Packaging | 10 Tablets in a Strip |
Strength | 200mg |
Delivery Time | 8 Days |
Product Name: Pirfenex 200mg Tablets
Brand Name: Pirfenex
Composition: Pirfenidone 200 mg
Form: Tablet
Packaging Size: 2 x 15 Tablets per Strip
Packaging Type: Strip
Minimum Order Quantity: 10 Strips
Manufacturer: Cipla
Medicine Type: Allopathic (Cardiopulmonary Medication)
Usage: Personal (As directed by physician)
Description:
Pirfenex 200mg contains Pirfenidone, an anti-fibrotic and anti-inflammatory agent used in the treatment of Idiopathic Pulmonary Fibrosis (IPF)—a chronic, progressive lung disease characterized by scarring and thickening of lung tissue, leading to difficulty in breathing. Pirfenidone works by reducing fibroblast proliferation and the production of inflammatory mediators, helping to slow disease progression and ease respiratory symptoms.
Indications:
Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF)
Mechanism of Action:
Pirfenidone acts by inhibiting the synthesis and release of fibrogenic mediators, thereby reducing lung fibrosis and inflammation.
Key Features:
Manufactured by Cipla, a trusted pharmaceutical company
Each tablet contains Pirfenidone 200 mg
Clinically proven to slow the progression of IPF
Available in convenient 2 x 15 tablet strip packaging
Product Name: Pirfenex 200mg Tablets
Brand Name: Pirfenex
Composition: Pirfenidone 200 mg
Form: Tablet
Packaging Size: 2 x 15 Tablets per Strip
Packaging Type: Strip
Minimum Order Quantity: 10 Strips
Manufacturer: Cipla
Medicine Type: Allopathic (Cardiopulmonary Medication)
Usage: Personal (As directed by physician)
Description:
Pirfenex 200mg contains Pirfenidone, an anti-fibrotic and anti-inflammatory agent used in the treatment of Idiopathic Pulmonary Fibrosis (IPF)—a chronic, progressive lung disease characterized by scarring and thickening of lung tissue, leading to difficulty in breathing. Pirfenidone works by reducing fibroblast proliferation and the production of inflammatory mediators, helping to slow disease progression and ease respiratory symptoms.
Indications:
Treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF)
Mechanism of Action:
Pirfenidone acts by inhibiting the synthesis and release of fibrogenic mediators, thereby reducing lung fibrosis and inflammation.
Key Features:
Manufactured by Cipla, a trusted pharmaceutical company
Each tablet contains Pirfenidone 200 mg
Clinically proven to slow the progression of IPF
Available in convenient 2 x 15 tablet strip packaging